BRIEF published on 11/06/2024 at 17:45, 14 days 20 hours ago Beneteau Reports Q3 Revenue Drop Amid Inventory Destocking Inventory Reduction Boat Division 2024 Forecasts Beneteau Revenue Housing Sale
REGULATED PRESS RELEASE published on 11/06/2024 at 17:40, 14 days 20 hours ago 241106 BENETEAU Revenue Q3-2024 Groupe Beneteau confirms continued destocking in networks, 2024 forecasts upheld. Boat division revenues down -33%, housing sale approved Groupe Beneteau Boat Division 2024 Forecasts Destocking Housing Sale
BRIEF published on 10/29/2024 at 15:44, 22 days 22 hours ago Groupe Beneteau Receives Approval to Sell Housing Division to Trigano Trigano Groupe Beneteau Housing Division French Competition Authority Boat Division Strategy
REGULATED PRESS RELEASE published on 10/29/2024 at 15:39, 22 days 22 hours ago 241029 BENETEAU Housing cession Groupe Beneteau receives French Competition Authority approval for the sale of its Housing Business to Trigano, facilitating a strategic shift towards boating focusing Trigano Groupe Beneteau Strategic Shift French Competition Authority Housing Business
BRIEF published on 09/30/2024 at 18:22, 1 month 20 days ago BENETEAU supports its Italian subsidiary GBI SPA with a debt waiver Italy BENETEAU GBI SPA Abandonment Of Debt Regulated Agreement
BRIEF published on 09/25/2024 at 17:45, 1 month 25 days ago BENETEAU Expects 4%-6% Operating Margin for 2024 Financial Performance Boat Division Operating Margin Strategic Goals BENETEAU 2024
BRIEF published on 09/25/2024 at 17:45, 1 month 25 days ago Beneteau H1 2024 Earnings Report: Resilience in Tough Markets Financial Performance Boat Division Market Outlook Adaptation Measures H1 2024 Results
REGULATED PRESS RELEASE published on 09/25/2024 at 17:40, 1 month 25 days ago 240925 BENETEAU Results H1-2024 Groupe Beneteau reports on H1 2024 financial results, with operating margin expected to reach 4% to 6%. Premiumization strategy and adaptation measures driving profitability Financial Results Groupe Beneteau Operating Margin Adaptation Measures Premiumization
BRIEF published on 08/26/2024 at 18:07, 2 months 25 days ago BENETEAU: Transactions on Own Shares Euronext Paris Financial Transactions Own Shares BENETEAU 2024
BRIEF published on 08/19/2024 at 12:35, 3 months 2 days ago Bénéteau: Transactions on own shares from August 12 to 16, 2024 Euronext Paris BENETEAU Stock Transactions Walk Weighted Price
Published on 11/21/2024 at 13:30, 38 minutes ago AirIQ Announces September 30, 2024 Quarterly Results Company Reports Double-Digit Growth in Recurring Revenue
Published on 11/21/2024 at 13:30, 38 minutes ago Datametrex Secures Additional P.O. Approx $250K for IT Services
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 1 hour 8 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 12:35, 1 hour 33 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour 53 minutes ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 06:58, 7 hours 10 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 18 hours 48 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 23 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 23 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
